They are evaluating the effectiveness of regenerative medicine in dogs with osteoarthritis that do not respond to pain medication.

Osteoarthritis (O.A.) represents degenerative joint disease in which chronic inflammation leads to loss of articular cartilage. This disease is the most common joint disease in dogs.

Dogs with advanced osteoarthritis sometimes suffer from chronic pain, decreased quality of life, and limited mobility, despite painkillers. Likewise, traditional treatment options for osteoarthritis may relieve symptoms but do not result in cartilage regeneration.

A scientific study recently published by researchers from the University of Munich attempted to evaluate the success of the treatment regenerative cell therapy in dogs with chronic OA that no longer respond to pain therapy.

And, as they point out, regenerative medicine getting bigger and bigger the focus of the investigation

in OA, since regenerative cells promote tissue healing.

Thus, the researchers assessed the effectiveness of a single intra-articular injection of the stromal vascular fraction (FVE) autologously in 23 dogs with chronic lameness caused by progressive elbow OA that did not respond to conventional pharmacological therapy.

Measurements of results during the period six month training included clinical and orthopedic examinations And radiographicobjective gait analysis and verified owner questionnaires.

As for the results, they note that in 19 out of 23 joints no progression of OA was observed radiographically. Peak vertical force was significantly improved at three months and vertical impulse at six months after injection compared with baseline.

“More than 33% of dogs demonstrated treatment-related improvement in lameness based on objective gait analysis. Owner questionnaires showed significant improvement in clinical signs throughout the study period, and 26% of dogs showed treatment-related improvements in pain scores as measured by questionnaires. A short list of pain in dogs

“, the researchers point out.

Finally, they note that the study results suggest that “autologous regenerative cell therapy may be a promising treatment option for dogs with advanced osteoarthritis that do not respond to conventional pharmacologic therapy.” Of course they warn that treatment did not improve clinical signs in all dogstherefore, it cannot be recommended for all patients.

COMBATING OA PAIN IN DOGS IN THE VETERINARY

Similar studies reflect growing concern between the scientific and veterinary communities in fight osteoarthritis and, above all, in improving the quality of life of dogs suffering from it.

For this reason, in addition to research, the animal health sector has opted to develop tools that help improve the quality of life for pets and animals. improve joint healthdemanded by pet owners who are increasingly concerned about the well-being of their dogs.

In this sense, veterinarians have at their disposal tools such as Omnichondro from HifarmaxA complementary complete food formulated to support and lubricate the joints of dogs and cats, containing ingredients that help nourish cartilage, helping to improve joint stability and flexibility.

Omnichondro contains the most high concentrations of glucosamine and chondroitinherbal extracts, antioxidant vitamins and bicationic cofactors. Glucosamine and chondroitin are important elements for nourishing articular cartilage, helping to improve joint elasticity and stability.

Herbal extracts work together with glucosamine and chondroitin to provide faster results. Vitamins and bicationic cofactors protect the joint from oxidative stress and promote better absorption of all ingredients, respectively.